Kronos Bio Inc (KRON) Return on Assets ROA from the first quarter of 2025 to first quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket
 


Kronos Bio Inc   (NASDAQ: KRON)


Kronos Bio Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Kronos Bio Inc 's ROA in the first quarter of 2025?
Kronos Bio Inc recorded a cumulative net loss of $-64 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -49.97%.

However, within the Healthcare sector 593 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 4113, from total ROA ranking in the fourth quarter of 2024 at 4872.

What is ROA?



Return On Assets (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Total Assets Change -35.43 % -38.13 % -36.66 % -36.67 % -36.24 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -64 -86 -86 -103 -116
Return On Assets (TTM) -49.97 % -59.83 % -52.71 % -56.44 % -57.04 %
KRON's Total Ranking # 4113 # 4872 # 4229 # 4312 # 4366
Total Assets (TTM) in million 108 120 137 151 167
Seq. Total Assets Change -9.92 % -12.47 % -9.07 % -9.93 % -13.68 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 262
Sector # 594
Overall # 4059

Return On Assets Statistics
High Average Low
63.04 %
-31.1 %
-55.39 %
(Dec 31 2020)  



  News about Kronos Bio Inc Return on Assets ROA

Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement Amid Financial Challenges



In a move to propel its pipeline advancement and streamline operations, Kronos Bio Inc has recently implemented a new leadership structure. This restructuring includes the elimination of three executive officer roles and the appointment of a new Executive Leadership team. However, these strategic changes come at a time when the company has recorded a significant net loss and faces challenges in the Healthcare sector.
Facts:
Kronos Bio Inc reported a cumulative net loss of $-119 million during the 12 months ending in the third quarter of 2023. This financial setback has resulted in a concerning negative return on assets (ROA) of -48.26%. Such a negative ROA indicates that the company s assets are not generating profit and raises concerns regarding its financial stability.




Financial Statements
Kronos Bio Inc 's Assets $ 108 million KRON's Balance sheet
Kronos Bio Inc 's Income $ -8 million Quarterly KRON's Income Statement
KRON's Income by Division See KRON's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
Y / Y Total Assets Change -38.13 % -28.15 % -22.75 % -25.6 % -
Total Assets in million 120 194 270 350 470
Y / Y Net Income Change - - - - -
Net Income in million -86 -113 -133 -151 -88
Annual Return On Assets -71.7 % -58.07 % -49.33 % -43.22 % -18.83 %




More Return On Assets Ratios
KRON's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KRON's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KRON's Competitors
Subscribers only: Roa for Kronos Bio Inc 's Suppliers
Subscribers only: Return On Assets for KRON's Customers

You may also want to know
KRON's Roi KRON's Inventory Turnover Ratio KRON's Growth Rates KRON's Dividend Comparisons
KRON's Profitability Ratios KRON's Asset Turnover Ratio KRON's Dividend Growth
KRON's Roe KRON's Valuation Ratios KRON's Financial Strength Ratios KRON's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA


Date modified: 2026-09-26T07:39:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.